- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

 

---

---

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 000-51323

 

Micrus Endovascular Corporation  

(Exact name of registrant as specified in its charter)

 

821 Fox Lane

San Jose, California 95131, [phone]

 

(Address, including zip code, and telephone number, including area code,

of registrant’s principal executive offices)

 

Common Stock, par value $0.01 per share  

 

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file

reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	x
	Rule 12g-4(a)(2)	o
	Rule 12h-3(b)(1)(i)	x
	Rule 12h-3(b)(1)(ii)	o
	Rule  15d-6	o

 

Approximate number of holders of record as of the certification or notice date: 1

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Micrus Endovascular Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:  September 27, 2010	MICRUS ENDOVASCULAR CORPORATION
	By:	/s/ Clifford Birge
		Clifford Birge
		Secretary

 

 

---

---